Sort   by:  
 Page size 
UnknownEffect of CYP3A4*22, CYP3A5*3, and CYP3A Combined Genotypes on Cyclosporine, Everolimus, and Tacrolimus Pharmacokinetics in Renal Transplantation.
Not available
S-EPMC3944116 | biostudies-literature
UnknownPharmacogenomics-guided personalized medicine in a clinical setting: real-world data.
Not available
S-EPMC12846737 | biostudies-literature
UnknownMeta-analysis on the association of VEGFR1 genetic variants with sunitinib outcome in metastatic renal cell carcinoma patients.
Not available
S-EPMC5352048 | biostudies-literature
UnknownClinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.
Not available
S-EPMC5760397 | biostudies-literature
UnknownAssociation of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma.
Not available
S-EPMC4643117 | biostudies-literature
UnknownTowards Fixed Dosing of Tocilizumab in ICU-Admitted COVID-19 Patients: Results of an Observational Population Pharmacokinetic and Descriptive Pharmacodynamic Study.
Not available
S-EPMC8502793 | biostudies-literature
UnknownPopulation pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients.
Not available
S-EPMC4713720 | biostudies-literature
UnknownDutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate.
Not available
S-EPMC10689464 | biostudies-literature
UnknownDutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics.
Not available
S-EPMC10923774 | biostudies-literature
UnknownPopulation Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing.
Not available
S-EPMC7809008 | biostudies-literature
Sort   by:  
 Page size